Evidence map›Paper›PMID 24785948›Full record

ArticleAIDS (London, England)2014

Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.

Nienke H van Teijlingen, Angelique Hölzemer, Christian Körner, Wilfredo F García-Beltrán, Jamie L Schafer, Lena Fadda, Todd J Suscovich, Christian Brander, Mary Carrington, David T Evans and 2 more

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Stable Frequencies of HLA-CFrontiers in immunology · 2018
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Nienke H van TeijlingenaRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA bExperimental Immunology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands cDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston dDivision of Microbiology, New England Primate Research Center, Southborough, Massachusetts, USA eIrsicaixa AIDS Research Institute - HIVACAT, Autonomous University of Barcelona, Badalona and Institució Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain fCancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC Frederick, Inc., Frederick National Laboratories for Cancer Research, Frederick, Maryland gDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA hLaboratory for Translational Immunology, University Medical Center Utrecht, Utrecht iCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands jHeinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany. *Nienke H. van Teijlingen and Angelique Hölzemer have contributed equally to the writing of the manuscript.
Angelique Hölzemer
Christian Körner
Wilfredo F García-Beltrán
Jamie L Schafer
Lena Fadda
Todd J Suscovich
Christian Brander
Mary Carrington
David T Evans
Debbie van Baarle
Marcus Altfeld
Ragon Institute of MGH, MIT and Harvard · USHarvard University · USAcademic Medical Center · NLFrederick National Laboratory for Cancer Research · USInstitució Catalana de Recerca i Estudis Avançats · ESUniversity Medical Center Utrecht · NL

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Effects of genetic polymorphism in MHC, KIR, and related loci on human diseaseZIABC010791 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRINGTON, MARY N. · 2009 to 2025
$18.2M
NK cell mediated immune pressure in HIV-1 infectionR01AI067031 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALTFELD, MARCUS · 2006 to 2015
$4.4M
KIR and MHC Class I Immunogenetics in SIV InfectionR01AI095098 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI EVANS, DAVID T · 2012 to 2016
$2.7M
CCR NIH HHS HHSN261200800001CIntramural NIH HHSNCI NIH HHS HHSN261200800001ENIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI066031NIAID NIH HHS R01 AI067031NIAID NIH HHS R01 AI095098NIAID NIH HHS R01AI095098
6 · The paper itself

Abstract

objectiveThe aim of this study was to assess the consequence of sequence variations in HLA-C03:04-presented HIV-1 p24 Gag epitopes on binding of the inhibitory natural killer (NK) cell receptor KIR2DL2 to HLA-C03:04.

designHIV-1 may possibly evade recognition by KIR+ NK cells through selection of sequence variants that interfere with the interactions of inhibitory killer cell immunoglobulin-like receptors (KIRs) and their target ligands on HIV-1 infected cells. KIR2DL2 is an inhibitory NK cell receptor that binds to a family of HLA-C ligands. Here, we investigated whether HIV-1 encodes for HLA-C03:04-restricted epitopes that alter KIR2DL2 binding.

methodsTapasin-deficient 721.220 cells expressing HLA-C03:04 were pulsed with overlapping peptides (10mers overlapped by nine amino acids, spanning the entire HIV-1 p24 Gag sequence) to identify peptides that stabilized HLA-C expression. The impact that sequence variation in HLA-C03:04-binding HIV-1 epitopes has on KIR2DL2 binding and KIR2DL2+ NK cell function was determined using KIR2DL2-Fc constructs and NK cell degranulation assays.

resultsSeveral novel HLA-C03:04 binding epitopes were identified within the HIV-1 p24 Gag consensus sequence. Three of these consensus sequence peptides (Gag144-152, Gag163-171 and Gag295-304) enabled binding of KIR2DL2 to HLA-C03:04 and resulted in inhibition of KIR2DL2+ primary NK cells. Furthermore, naturally occurring minor variants of epitope Gag295-304 enhanced KIR2DL2 binding to HLA-C03:04.

conclusionOur data show that naturally occurring sequence variations within HLA-C03:04-restricted HIV-1 p24 Gag epitopes can have a significant impact on the binding of inhibitory KIR receptors and primary NK cell function.

Indexed as

Genetic VariationCell DegranulationCell LineEpitopesHIV Core Protein p24HLA-C AntigensHumansKiller Cells, NaturalProtein BindingReceptors, KIR2DL2EpitopesHIV Core Protein p24HLA-C*03:04 antigenHLA-C AntigensKIR2DL2 protein, humanReceptors, KIR2DL2

Identifiers

PMID24785948
PMCPMC4453925
OpenAlexW2040133121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.